Cristina G. C.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
Data & Insights
Has run more than one trial at 145 of 332 partner sites.
Specializations
Precision Oncology in Colorectal Cancer
The investigator specializes in targeted therapeutic approaches for colorectal cancer with specific genetic mutations, including BRAF V600E mutations, KRAS G12C mutations, and HER2-positive disease states.
- BRAF/KRAS Wild-type Colorectal Cancer Management
- Mutation-specific Treatment Strategies
- Advanced Metastatic Disease Therapy
Their work encompasses novel combination approaches using targeted therapies with established treatments for optimized patient outcomes.
Innovative Treatment Combinations
Focus on developing and evaluating novel therapeutic combinations including targeted biologics, immunotherapy agents, and conventional chemotherapy regimens for colorectal cancer treatment.
- Targeted Therapy Integration
- Chemotherapy Optimization
- Biological Agent Combinations
Expertise in coordinating complex treatment protocols that combine multiple therapeutic modalities.
Personalized Medicine Approaches
Leading research in personalized treatment strategies based on molecular profiling and biomarker analysis, including ctDNA-guided therapy for early-stage and advanced colorectal cancer.
- Molecular-guided Treatment Selection
- Biomarker-based Therapy
- Post-surgical Treatment Optimization
Integration of genomic analysis for tailored therapeutic decision-making in various disease stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.